Diabetes mellitusProgress and opportunities in the evolving epidemic: Cell Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5 NR4a1 axis Nature Communications PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar Weight loss with GLP 1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Precision obesity medicine: A phenotype guided framework for pharmacologic therapy across the lifespan Journal of Endocrinological Investigation Springer Nature Link